Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PTC-299/aromatase inhibitor combinations deemed feasible in breast cancer trial

Oct. 11, 2010

MV-062926 is active in mouse model of COPD

Oct. 8, 2010

Eisai details in vitro and in vivo activity of new antifungal E-1210

Oct. 8, 2010

Extended proof-of-concept and drug interaction studies complete for IDX-899

Oct. 8, 2010

Preclinical and early clinical data reported on BC-3781

Oct. 8, 2010

Artemether sublingual spray is safe and efficacious in children with severe malaria

Oct. 7, 2010

SNPs in PIK3C2B gene correlate with risk of Parkinson's disease

Oct. 7, 2010

Neutrophil elastase inhibitor AZD-9668 shows promise in COPD

Oct. 7, 2010

Tuberculosis candidate PNU-100480 is well tolerated in healthy volunteers

Oct. 7, 2010

LMV-601 is potently active against HSV and HPV in preclinical studies

Oct. 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...